• Purpose

    Committed to solving the BIGGEST problems related to transplant


  • Projects

    Ending Transplant Failure
    The Complete Transplant Patient Initiative
    Solving the Organ Donor Shortage


  • Collaborators

    Working together to build a better future

  • Core Services

    Data Science, PROs, Education,
    Core Lab Testing, and more


We are are optimistic scientists and clinicians working to innovate and solve the the biggest problems related to organ transplantation. 

At the Terasaki Research Institute, we believe in helping people live longer and the success of transplantation. In collaboration with leading physicians, scientists, and the biotechnology/pharmaceutical industry, we will solve the major problems leading to and limiting the access and success of transplantation. We support our family of the brightest data scientists, health services researchers, biostatisticians, and translational scientists. Our unique culture allows for superior academic research, creativity, and collaboration. We value collaboration, innovation, the patient's well being, honesty, and integrity. Our willingness and ability to focus on the patient’s needs and collaborate with the entire transplant community is one of our major strengths. As an independent non-profit research institute, we do research with medical centers worldwide, serve as a core lab on research grants, conduct in depth data analysis, have major health literacy and education programs, work within and help develop research consortia, run organ transplant registries, and work with technology, biotechnology, and pharmaceutical partners to innovate.




Our initiatives to achieve our vision:

Ending Transplant Failure Initiative

Poor long-term survival of a transplanted organ (allograft) is one of the major problems in transplant today. Circulating antibodies directed toward donor human leukocyte antigens (HLA) (donor-specific anti-HLA antibodies, DSA) are now thought to be the major cause of allograft loss. Although we know more about these antibodies and their ability to injure the transplanted organ than we did even a decade ago, we still have much learn.

We must develop a stronger understanding of antibody mediated injury in transplant and develop new diagnostic and therapeutic tools to eradicate this problem in transplant. Here at the Terasaki Research Institute, we are working to make this happen.

Learn More

The Complete Transplant Patient Initiative

At the Terasaki Research Institute, we are keenly focused on working together with transplant patients to get a better understanding of their habits, preferences, and quality of life. We want to make transplant care, transplant medications, and the entire transplant process better fit the needs of the transplant patients. We believe that we can combine the patient's needs and thoughts with our basic science research and transplant education to make a transplant recipient's life better.

This requires basic scientists, clinicians, and health services researchers to work together WITH the patient.  Here at the Terasaki Research Institute, we want to solve problems with the whole patient in mind.

Learn More

Solving the Organ Donor Shortage

Patients are waiting for transplants and dying while waiting. In 2016, in the U.S., 19,061 chronic kidney disease patients received a kidney transplant while 9,246 more patients died or became too ill to remain on the transplant list. This problem is also a major issue in heart, lung, liver, pancreas, and small bowel transplant. In kidney transplant where living donation is possible, less than 1/3 of all transplants are done this way. We at the Terasaki Research Institute are working to solve the organ donor shortage.


We must make organ transplant available for those who need it. We also need to decrease the risk of death for those still waiting for a transplant.

Learn More